What is it about?

Hearing loss following exposure to certain therapeutic drugs and or environmental hazards can have long-lasting consequences that are likely to threaten a person’s quality of life. This work brings together the expertise and real-world experiences of auditory researchers and clinicians from the International Ototoxicity Management Group (IOMG) to address issues related to the ongoing management of individuals exposed to ototoxic agents that pose risk to hearing and/or balance. The authors discuss how to effectively integrate Ototoxicity Management (OtoM) into clinical practice and what tools and considerations should be understood to support patients.

Featured Image

Why is it important?

Elements of ototoxicity management vary across the lifespan. Understanding how best to prevent, diagnose, monitor, and treat patients exposed to ototoxic medications and/or environmental ototoxicants should be a continuous effort. New tools, new treatments, and new approaches to integrating OtoM in the clinic are constantly evolving. What’s new in ototoxicity management? connects practicing clinicians with basic science and clinical researchers to discuss the latest advances in the field to better address their patients’ needs.

Read the Original

This page is a summary of: What's New in Ototoxicity Management?, Perspectives of the ASHA Special Interest Groups, December 2023, American Speech-Language-Hearing Association (ASHA),
DOI: 10.1044/2023_persp-23-00153.
You can read the full text:

Read

Contributors

The following have contributed to this page